Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
401
FDA:400
NMPA:1
Drug Approvals
Methocarbamol Injection
- Product Name
- 美索巴莫注射液
- Approval Number
- 国药准字HJ20240009
- Approval Date
- Apr 17, 2024
NMPA
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)
Phase 1
Completed
- Conditions
- Hypoglycemia
- Interventions
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2014-03-13
- Lead Sponsor
- Fresenius Kabi USA, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT02086227
- Locations
- 🇺🇸
West Houston Clinical Research Services, 2026 Wirt Road, Houston, Texas, United States
News
Smart Drug Delivery Systems Market Poised for 17% Growth as Chronic Disease Management Evolves
The global smart drug delivery systems market reached $12 billion in 2024 and is projected to grow at a CAGR of 17% through 2034, driven by rising chronic disease prevalence and technological advancements.